Literature DB >> 3626434

[Diagnosis and prognosis of hairy cell leukemia].

W Hill, G Kettner, R Burkhardt.   

Abstract

During 1966 and 1986 202 patients with hairy cell leukemia in the bone marrow biopsy were observed. All hairy cells were categorized according to their nuclear morphology into ovoid subtype, convoluted subtype and indented subtype. The overall survival of 113 non-splenectomised patients was 11 months. However, the median survival time of each subtype differed considerably with 55 months for the ovoid subtype, 8 months for the convoluted and 6 months for the indented type. The prognosis of splenectomy patients were significantly better at a p-value of less than 0.0001 than the survival of the non-splenectomised patients. The median survival time was 59 months. Also in this group of patients the prognosis was different for the ovoid, convoluted and indented subtype. The median survival time of the ovoid subtype is not yet reached, despite a observation time of more than 180 months. In contrast, the survival time for the convoluted and indented subtypes was 26 months. These data elucidate that at least part of the heterogeneity in the clinical course of this disease can be explained by the morphologically distinct subtypes and that splenectomy prolongs profoundly but to a different degree the survival of patients with all three histological subtypes. The response rate to r.-IFN alpha-2b is higher in patients with the ovoid than with the convoluted and indented subtypes.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3626434     DOI: 10.1007/BF01875508

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  15 in total

1.  Prognosis and therapy in hairy cell leukemia.

Authors:  J Jansen; G J den Ottolander; R S Holdrinet; G J Tricot; J Hermans
Journal:  Semin Oncol       Date:  1984-12       Impact factor: 4.929

2.  Hairy cell leukemia: clinical presentation and follow-up of 211 patients.

Authors:  G Flandrin; F Sigaux; G Sebahoun; P Bouffette
Journal:  Semin Oncol       Date:  1984-12       Impact factor: 4.929

3.  Bone marrow histology in hairy cell leukemia. Identification of subtypes and their prognostic significance.

Authors:  R Bartl; B Frisch; W Hill; R Burkhardt; W Sommerfeld; M Sund
Journal:  Am J Clin Pathol       Date:  1983-05       Impact factor: 2.493

4.  Therapy of hairy-cell leukemia.

Authors:  D W Golde
Journal:  N Engl J Med       Date:  1982-08-19       Impact factor: 91.245

5.  [Technical improvement and application of histo-biopsy in bone marrow and bones].

Authors:  R Burkhardt
Journal:  Klin Wochenschr       Date:  1966-03-15

6.  Treatment of hairy cell leukemia with recombinant alpha 2 interferon.

Authors:  M J Ratain; H M Golomb; J W Vardiman; E E Vokes; R H Jacobs; K Daly
Journal:  Blood       Date:  1985-03       Impact factor: 22.113

7.  Interferon in the treatment of hairy cell leukemia.

Authors:  J A Thompson; A Fefer
Journal:  Cancer       Date:  1987-02-01       Impact factor: 6.860

8.  Hairy cell leukemia: a five-year update on seventy-one patients.

Authors:  H M Golomb; D Catovsky; D W Golde
Journal:  Ann Intern Med       Date:  1983-10       Impact factor: 25.391

Review 9.  Leukemic reticuloendotheliosis (hairy cell leukemia).

Authors:  B A Bouroncle
Journal:  Blood       Date:  1979-03       Impact factor: 22.113

10.  Clinical staging system for hairy-cell leukemia.

Authors:  J Jansen; J Hermans
Journal:  Blood       Date:  1982-09       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.